Viewing Study NCT05550532


Ignite Creation Date: 2025-12-24 @ 9:34 PM
Ignite Modification Date: 2025-12-27 @ 7:20 PM
Study NCT ID: NCT05550532
Status: COMPLETED
Last Update Posted: 2025-05-25
First Post: 2022-09-20
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: A Study of Aticaprant 10 Milligrams (mg) as Adjunctive Therapy in Adult Participants With MDD With Moderate-to-severe Anhedonia and Inadequate Response to Current Antidepressant Therapy
Sponsor: Janssen Research & Development, LLC
Organization:

Key Dates - Follows AllAPIJSON File Order

Start Date: 2022-12-06
Start Date Type: ACTUAL
Primary Completion Date: 2024-11-08
Primary Completion Date Type: ACTUAL
Completion Date: 2024-11-13
Completion Date Type: ACTUAL
First Submit Date: 2022-09-20
First Submit QC Date: None
Study First Post Date: 2022-09-22
Study First Post Date Type: ACTUAL
Results First Submit Date: None
Results First Submit QC Date: None
Results First Post Date: None
Results First Post Date Type: None
Results First Post QC Date: None
Results First Post QC Date Type: None
Disp First Submit Date: None
Disp First Submit QC Date: None
Disp First Post Date: None
Disp First Post Date Type: None
Last Update Submit Date: 2025-05-23
Last Update Post Date: 2025-05-25
Last Update Post Date Type: ACTUAL